Moderna, Inc. (MRNA) stock analysis

MRNA · Moderna, Inc.

Latest recorded price: USD 215.27

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -53.4%, free cash flow margin -106.2%, ROIC -59.7%. The model flags 3 risk signals for this company (2 high severity).

Similar companies in Healthcare